Direkt zum Inhalt
Merck

Human Pluripotent Stem Cell Expansion in Stirred Tank Bioreactors.

Methods in molecular biology (Clifton, N.J.) (2019-05-28)
Felix Manstein, Caroline Halloin, Robert Zweigerdt
ZUSAMMENFASSUNG

This chapter describes a detailed protocol on human pluripotent stem cells (hPSCs) cultivation as matrix-free cell-only aggregates in defined and xeno-free culture medium in stirred tank bioreactors (STBRs). Starting with a frozen stock pre-expanded on conventional culture dishes (2D), the ultimate process is performed in 150 mL culture scale in stirred tank bioreactors (3D) and is designed to produce up to 500 million pluripotent hPSC within 7 days. The culture strategy includes perfusion-based cell feeding facilitating process control, automation, and higher cell yields. Ultimately, this detailed protocol describes an important step for generating a defined starting cell population for directed lineage differentiation and subsequently fueling human cell-based assays and regenerative medicine approaches.

MATERIALIEN
Produktnummer
Marke
Produktbeschreibung

Sigma-Aldrich
Insulin -Lösung human, sterile-filtered, BioXtra, suitable for cell culture
Sigma-Aldrich
Natriumselenit, BioReagent, suitable for cell culture, ≥98%
Sigma-Aldrich
Albumin human, recombinant, expressed in Saccharomyces cerevisiae, aqueous solution, 10% in aqueous buffer, ≥99% (agarose gel electrophoresis)
Sigma-Aldrich
Transferrin human, Optiferrin, recombinant, expressed in rice